McKesson Corporation

(New York Stock Exchange)
Back to all articles
Slightly Bullish +25

McKesson Corporation (MCK) Stock Price, News, Quote & History - Yahoo Finance

AI-generated analysis

⚠️ Market data on this page is currently experiencing temporary issues and showing delayed quotes.

πŸ“Š Analysts project McKesson (MCK) will report $11.56 EPS and $101.88 billion in revenue for its Q4 earnings report.

πŸ’Ό The company operates across four segments including U.S. Pharmaceutical, RxTS, Medical-Surgical Solutions, and International divisions.

πŸ“‰ Recent stock performance has lagged behind broader market trends despite the company demonstrating strong growth historically.

πŸ“œ McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

πŸ’° The U.S. Pharmaceutical segment distributes various drugs including branded, generic, specialty, biosimilar, and over-the-counter pharmaceuticals.

🀝 The RxTS segment connects patients with healthcare partners such as pharmacies, providers, and biopharma companies to improve medicine access.

πŸ₯ Medical-Surgical Solutions offers supply distribution and services to hospitals, surgery centers, and long-term care facilities.

🌍 The International segment delivers medicines and IT solutions to retail pharmacies, hospitals, and clinics outside the U.S.

πŸ“‰ Year-to-date market performance shows significant losses across major indices including the Dow Jones, S&P 500, and Nasdaq.

πŸ—“οΈ Current market focus includes interest rate expectations, global economic sentiments, and oil price fluctuations due to geopolitical tensions.

πŸ›οΈ This quarter is categorized as 'Fed week,' with investors closely monitoring Federal Reserve thoughts on the economy and global affairs.

Bullish Signals
  • McKesson Corporation is preparing for its Q4 earnings report with analysts projecting strong performance, estimating $11.56 in EPS and $101.88 billion in revenue.
  • The company operates through four robust segments: U.S. Pharmaceutical, Prescription Technology Solutions, Medical-Surgical Solutions, and International, providing essential healthcare services globally.
  • McKesson has a long-standing heritage with roots dating back to 1833 and is headquartered in Irving, Texas, demonstrating stability in the medical distribution industry.
  • The company recently declared a quarterly dividend, indicating a commitment to returning value to its shareholders.
Risk Factors
  • Recent stock performance for McKesson (MCK) has lagged behind broader market trends, raising questions about future momentum.
  • The company operates through four segments including one being spun off (Medical-Surgical), which may introduce restructuring complexities or integration risks.
  • As part of 'Fed week,' the market faces uncertainty regarding interest rate movements and global economic conditions that could negatively impact investor sentiment.
  • Stocks are already down year-to-date (Dow and S&P 500 down 3%, Nasdaq almost 5%), creating a challenging environment for potential earnings-related rallies.
  • External geopolitical factors such as the war in Iran causing wide oil price swings may introduce cost inflation risks on McKesson's distribution margins.
Full Analysis
McKesson Corporation (MCK) is currently preparing to release its Q4 earnings report, with Wall Street analysts projecting an earnings per share (EPS) of $11.56 and revenue of $101.88 billion. Despite demonstrating strong growth over recent periods, the company's stock performance has lagged behind broader market trends, prompting questions regarding its future momentum. The article notes that McKesson operates within the Medical Distribution / Healthcare sector and has been in business since its founding in 1833. McKesson provides healthcare services both in the United States and internationally through four primary segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions (RxTS), and Medical-Surgical Solutions (which was spun-off from the broader medical-surgical segment). The North American Pharmaceutical segment distributes various drugs and offers business solutions to pharmacies, while RxTS serves biopharma partners and provides technology solutions to connect patients with necessary medicines. The Oncology & Multispecialty segment focuses on oncology services, and the Medical-Surgical Solutions segment supplies healthcare providers ranging from physician offices to hospitals and home health agencies. The company is headquartered in Irving, Texas. The broader market context during this period is described as "Fed week," where no interest rate movement is expected, though investors remain attentive to Federal Reserve comments on the global economy and domestic conditions. Oil prices are also under scrutiny due to price volatility linked to the war in Iran. As of the last update on April 28, 2026, major indices including the Dow Jones Industrial Average and S&P 500 have declined approximately 3% year to date, while the Nasdaq is down nearly 5%. The article also mentions that the company recently declared a quarterly dividend and highlights ongoing analyst focus on its valuation, earnings growth expectations, and insider trading sentiment. The content includes various related headlines focusing on McKesson's trending status, dividend declarations, and comparative analyses with other medical stocks like Cardinal Health and Global Medical Products Holdings (GMDP). It also provides definitions for key financial metrics such as Fair Value, trailing total returns calculated against the S&P 500 benchmark, insider sentiment analysis, and hiring trends as indicators of company health. The text serves as an informational summary combining earnings previews, corporate segment overviews, and current market conditions surrounding McKesson's stock performance.